Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

<< Previous

Bullboard Posts

Next >>

Post by SundayMovieson Dec 20, 2022 10:11am

127 Views

Post# 35181936

IF? When? How much?

IF?

The interim data is so strong that we can assume that Bracelet results will be stellar.
The big pharma has a 90 days exclusive period.

When?

Bracelet-1 final results are expected in the coming 6 months.

How Much?

Well, this where we will get a vey bad deal if SP keeps on staying low. The market needs to start believing here a bit... We got the technical indicators flashing green. We need share price to rally so that it can rally further. A good pre-deal range would be at 6$ USD - 350 millions. ONCY can argue that they don't need cash as they can refinance and up the bidding.

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles